ClinicalTrials.gg
Not yet recruitingNCT07433218FRESHUpdated Sep 15, 2026

Frequency of Electrical Acupoint Stimulation on Hypotension During Induction

An interventional study of electrical acupoint stimulation and electrodes pasted in Anesthesia, Post-induction Hypotension (PIH) and Transcutaneous Electrical Acupoint Stimulation, sponsored by Zhihong LU. Not yet recruiting. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-09-15.

Sponsored by Zhihong LU · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
204
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

From 15 minutes before to 15 minutes after anesthesia, Transcutaneous Electrical Acupoint Stimulation(TEAS) at different frequencies will be applied at Neiguan and Jian Shi. The changes in blood pressure during the anesthesia induction period will be compared among the high-frequency group ,the low-frequency group and the control group to explore the better frequency to reduce the incidence of post-induction hypotension(PIH) in the elderly.

02

Conditions studied

  • Anesthesia
  • Post-induction Hypotension (PIH)
  • Transcutaneous Electrical Acupoint Stimulation

Browse trials for

Keywords

  • transcutaneous electrical acupoint stimulation
  • frequency
  • hemodynamic stability
03

In context

Hypotension

885 studies on the registry are indexed under Hypotension; 195 are open to participants now.

This study's planned enrollment of 204 is above the median of 87 across 590 interventional studies indexed under Hypotension.

Browse Hypotension studies →

Lead sponsor

Zhihong LU is the lead sponsor of 17 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • aged over 65 yrs old
  • elective abdominal surgery under general anesthesia
  • written infromed consent

Exclusion criteria

Exclusion Criteria:

  • status over 3
  • (NYHA) Functional Classification≥Ⅲ
  • severe arrhythmia leading to hemodynamic instability
  • uncontrolled diabetes
  • hypertension patients stratified as very high risk according to cardiovascular risk classification
  • people who have TEAS such as local acupoint skin injury or infection and implanted cardiac pacemaker
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

NYHA class (heart failure)

The New York Heart Association’s four classes of how much heart failure limits physical activity.

I
No limits: ordinary activity causes no undue tiredness or breathlessness.
II
Slight limits: comfortable at rest, ordinary activity causes symptoms.
III
Marked limits: comfortable at rest, less than ordinary activity causes symptoms.
IV
Symptoms even at rest; any activity makes them worse.

Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Care provider, Investigator, Outcomes assessor)
Enrollment
204 participants (estimated)

Study arms

  • Experimental
    High-frequency

    The electrical stimulation is provided at a frequency of 100Hz

    Other: electrical acupoint stimulation · Other: electrodes pasted · Other: high-frequency electrical stimulation

  • Experimental
    Low-frequency

    The electrical stimulation is provided at a frequency of 2Hz

    Other: electrical acupoint stimulation · Other: electrodes pasted · Other: low-frequency electrical stimulation

  • Sham comparator
    No stimulation

    Only electrodes are pasted

    Other: electrodes pasted

Interventions

  • Otherelectrical acupoint stimulation

    electrical acupoint stimulation are administered at Neiguan and Jian Shi. The stimulation starts at 15 minutes before anesthesia induction and ends at 15 minutes after anesthesia induction.

  • Otherelectrodes pasted

    Electrodes are pasted at Neiguan and Jianshi

  • Otherhigh-frequency electrical stimulation

    The frequency of electrical stimulation is 100Hz

  • Otherlow-frequency electrical stimulation

    The frequency of electrical stimulation is 2Hz

06

What researchers measure

Primary outcomes

  1. incidence of hypotension

    Hypotension is defined as a Mean arterial pressure (MAP) reduction of more than 20% from baseline or a MAP less than 65 mm Hg for at least 30 seconds. The baseline MAP is measured during the 5 minutes before start of intervention

    Time frame: from start of anesthesia induction to 15 minutes after induction

Secondary outcomes

  1. The area under the curve representing the change in mean arterial pressure during the induction period relative to the baseline.

    The area under the curve (AUC) below baseline mean arterial pressure (MAP) is calculated as: ∑ (((Si - Sbaseline)+(Si-1 - Sbaseline))/2 × ΔX) where Sbaseline is the baseline MAP, Si is the MAP at the i-th minute (i = 1…15), and ΔX is the time interval between two measurements.

    Time frame: from start of induction to 15 minutes after induction

  2. The dosage of vasoactive drugs

    Any MAP drop by more than 20% from baseline or a MAP less than 65 mm Hg for at least 1 minute within the first 15 minutes after general anesthesia induction triggered the administration of norepinephrine boluses (5 μg). If hypotension persisted after 2 boluses, a norepinephrine infusion (0.02-0.3 μg/kg/min) was initiated and continued until the MAP became stable and reached 65 mm Hg or higher. If hypotension reoccurred, 2 boluses of norepinephrine were repeated.

    Time frame: from start of induction to 15 minutes after induction

  3. lowest MAP

    Time frame: from start of induction to 15 minutes after induction

  4. standard deviation of R-R intervals (SDRR)

    assessed from the electrocardiography, key index of heart rate variability (HRV)

    Time frame: from start of induction to 15 minutes after induction

  5. ratio of low-frequency HRV/high-frequency HRV (LF/HF ratio)

    assessed from the electrocardiography,High-frequency HRV (HF-HRV) at 0.15-0.4 Hz and low-frequency HRV (LF-HRV) at 0.04-0.15 Hz

    Time frame: from start of induction to 15 minutes after induction

  6. major in-hospital complication incidence within 5 postoperative days

    major in-hospital complication incidence within 5 postoperative days

    Time frame: from start of anesthesia to the 5 days after anesthesia

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Kaduk K, Petrella A, Muller SJ, Koenig J, Kroemer NB. Non-Invasive Auricular Vagus Nerve Stimulation Decreases Heart Rate Variability Independent of Caloric Load. Psychophysiology. 2025 Feb;62(2):e70017. doi: 10.1111/psyp.70017. PubMed 40007175 ↗
  • Chaitman BR, Bitar SR. Is ST segment elevation non-Q-wave myocardial infarction after thrombolytic therapy a new clinical entity that requires an invasive management strategy? J Am Coll Cardiol. 2001 Jan;37(1):26-9. doi: 10.1016/s0735-1097(00)01053-6. No abstract available. PubMed 11153749 ↗

Individual participant data

Plan to share: Yes — The de-identified data will be available with reasonable request from Dr. Zhihong Lu at deerlu23@163.com

Supporting information: Study protocol

Time frame: after publication

Access criteria: with request to Dr. Zhihong Lu

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2026; primary completion for Dec 2026, 3 months later.

Of 210 non-industry interventional studies with no phase under Hypotension, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 22. This study's planned 3 months is below that.

Counting every sponsor, half of 217 studies reached it within 12 months; a quarter within 6 and three quarters within 22.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 20, 2026
First posted
Feb 25, 2026
StartEst.
Sep 15, 2026
Primary completionEst.
Dec 31, 2026
CompletionEst.
Mar 1, 2027
Last update
Sep 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07433218
Lead sponsor
Zhihong LU
Responsible party
Zhihong LU (Professor, Air Force Military Medical University, China) — Sponsor-investigator
First posted
Feb 25, 2026
Start date
Sep 15, 2026 (estimated)
Primary completion
Dec 31, 2026 (estimated)
Completion
Mar 1, 2027 (estimated)
Last update
Sep 15, 2026

Study contacts

Zhihong Lu
Contact
deerlu23@163.com
86-13891975018

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion